Business
Press Release Feb 14 2023
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 14, 2023, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR CARBOPROST TROMETHAMINE INJECTION USP".
About this update from Caplin Point Laboratories Limited
[{"type":"text","content":" Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 14, 2023, titled \"CAPLIN STERILES GETS USFDA APPROVAL FOR CARBOPROST TROMETHAMINE INJECTION USP\". View Attachment","length":357,"tagName":"div"}]